Exor N.V.

In its 13F for Q2 2025 (holdings as of June 30, 2025, filed July 16, 2025), Exor N.V. reported 2 stock positions worth $4.7 billion. Its top holding was 0 at 93.8% of the portfolio, followed by Clarivate (CLVT, 6.2%). Compared with Q1 2025, it added to 1. The biggest buy was 0 (shares +6%).

Most Recent 13F
Q2 2026
Location
Amsterdam, P7
CIK
0001589122
Portfolio Value
$4.7B (Q2 2025)
SEC Filing
0000950123-25-006414 ↗ filed Jul 16, 2025

Holdings Value

0$2.0B$4.0B$6.0B Q1 2024: $3.3B Q1 2024 Q2 2024: $4.5B Q2 2024 Q3 2024: $5.9B Q3 2024 Q4 2024: $4.5B Q4 2024 Q1 2025: $4.7B Q1 2025 Q2 2025: $4.7B $4.7B Q2 2025 Q3 2025: $5.9B Q3 2025 Q4 2025: $5.6B Q4 2025 Q1 2026: $5.4B Q1 2026 Q2 2026: $5.5B Q2 2026

Holdings 2 stocks · $4.7B

0 93.80% 182,543,970 $4.4B Add +5.7%
CLVT Clarivate PLC 6.20% 67,294,884 $289.4M No change

Portfolio Sells Q1 2025 → Q2 2025

None this quarter.

Portfolio Buys Q1 2025 → Q2 2025

0 Add +5.7% 93.80% −0.52

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$5.5B0, VIA, CLVT
Q1 2026 3$5.4B0, VIA, CLVT
Q4 2025 3$5.6B0, VIA, CLVT
Q3 2025 3$5.9B0, VIA, CLVT
Q2 2025 2$4.7B0, CLVT
Q1 2025 2$4.7B0, CLVT
Q4 2024 2$4.5B0, CLVT
Q3 2024 2$5.9B0, CLVT
Q2 2024 2$4.5B0, CLVT
Q1 2024 2$3.3B0, CLVT